- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/64 - Proteinases derived from animal tissue, e.g. rennin
Patent holdings for IPC class C12N 9/64
Total number of patents in this class: 2376
10-year publication summary
|
169
|
190
|
186
|
185
|
196
|
156
|
147
|
175
|
145
|
20
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1138 |
90 |
| Modernatx, Inc. | 1276 |
49 |
| Regeneron Pharmaceuticals, Inc. | 4492 |
48 |
| Takeda Pharmaceutical Company Limited | 2710 |
43 |
| Bioverativ Therapeutics Inc. | 213 |
42 |
| Chr. Hansen A/S | 1086 |
37 |
| Alexion Pharmaceuticals, Inc. | 644 |
33 |
| The Children's Hospital of Philadelphia | 822 |
27 |
| The Trustees of the University of Pennsylvania | 4381 |
22 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 295 |
20 |
| Vertex Pharmaceuticals Incorporated | 1622 |
19 |
| Translate bio, Inc. | 414 |
19 |
| Board of Regents, The University of Texas System | 5981 |
16 |
| Novozymes A/S | 3340 |
16 |
| F. Hoffmann-La Roche AG | 7890 |
15 |
| The Regents of the University of California | 20339 |
15 |
| Omeros Corporation | 308 |
15 |
| Opko Biologics Ltd. | 78 |
15 |
| Research Development Foundation | 230 |
15 |
| Seikagaku Corporation | 178 |
14 |
| Other owners | 1806 |